| Sep 14 |
Companies Like Agios Pharmaceuticals (NASDAQ:AGIO) Are In A Position To Invest In Growth
|
| Sep 12 |
FDA Grants Orphan Drug Tag to AGIO's Tebapivat for Rare Cancer
|
| Sep 12 |
Agios Pharmaceuticals’ tebapivat gains FDA orphan drug designation
|
| Sep 11 |
Agios Announces FDA Orphan Drug Designation Granted to Tebapivat (AG-946) for Treatment of Myelodysplastic Syndromes (MDS)
|
| Sep 6 |
Why Is Zimmer (ZBH) Down 3.9% Since Last Earnings Report?
|
| Sep 5 |
Agios to Present at the 2024 Cantor Global Healthcare Conference on September 18, 2024
|
| Aug 27 |
Agios' Mitapivat: A Potential Blockbuster In Thalassemia Treatment
|
| Aug 9 |
Agios Pharmaceuticals, Inc. (AGIO): Are Street Analysts Bullish on This Top Caligan Partner Holding Right Now?
|
| Aug 9 |
Is Agios Pharmaceuticals, Inc. (AGIO) a Good Addition to Your Portfolio Now?
|
| Aug 6 |
Agios to receive $1.1B in milestone payments for vorasidenib approval
|
